Pharmacokinetics of evocalcet in secondary hyperparathyroidism patients receiving hemodialysis: first-in-patient clinical trial in Japan

PURPOSE: Cinacalcet is a positive allosteric modulator of calcium-sensing receptors in the parathyroid gland and an effective treatment for secondary hyperparathyroidism. However, this agent has considerable side effects and dosage limitations, which impair effective treatment. Therefore, we investi...

Descripción completa

Detalles Bibliográficos
Autores principales: Shigematsu, Takashi, Shimazaki, Ryutaro, Fukagawa, Masafumi, Akizawa, Tadao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6141109/
https://www.ncbi.nlm.nih.gov/pubmed/30254496
http://dx.doi.org/10.2147/CPAA.S171044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6141109/
https://www.ncbi.nlm.nih.gov/pubmed/30254496
http://dx.doi.org/10.2147/CPAA.S171044

Ejemplares similares